MedTrace Logo

A Comparative Study of Tumor Specific Mesocolic Excision and Complete Mesocolic Excision for Right Sided Colon Cancer : Asian Multicenter Retrospective Study

NCT06865586 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3326

Last updated 2025-03-10

No results posted yet for this study

Summary

The goal of this observational study is to determine the optimal surgical strategy based on oncologic outcomes in patients with stage I-III right-sided colon cancer who underwent curative right hemicolectomy.

The main question it aims to answer is: Is there a significant difference in 5-year recurrence-free survival (RFS) between patients treated with Complete Mesocolic Excision (CME) and those treated with tumor specific mesocolic excision (TSME)? Participants will include patients who underwent curative right hemicolectomy for right-sided colon cancer between 2015 and 2020 at eight institutions. They will be categorized into two groups based on the surgical technique received-CME group and TSME group-and evaluated for primary and secondary endpoints of 5-year recurrence-free survival (RFS) and overall survival (OS), respectively.

Conditions

  • Colon Cancer
  • Lymph Node Dissection
  • Laparoscopic Colon Surgery
  • Robotic Surgical Procedure

Sponsors & Collaborators

  • Korea University Anam Hospital

    collaborator OTHER

  • Kyungpook National University Chilgok Hospital

    collaborator OTHER

  • Severance Hospital

    collaborator OTHER

  • Chinese University of Hong Kong

    collaborator OTHER

  • Pamela Youde Nethersole Eastern Hospital

    collaborator OTHER

  • North District Hospital

    collaborator OTHER

  • China Medical University Hospital

    collaborator OTHER

  • Asan Medical Center

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2020-12-31
Completion
2025-01-15

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06865586 on ClinicalTrials.gov